Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Uric acid is an endogenous purine metabolite that also functions as a potent plasma antioxidant. It has demonstrated neuroprotective effects in models of Parkinson's disease by inhibiting oxidative damage and neuronal cell death, modulating neuroinflammation, and activating the Nrf2-ARE signaling pathway. Elevated levels of uric acid (hyperuricemia) are associated with an increased risk of type 2 diabetes, where it can cause pancreatic β-cell death and dysfunction through the NF-κB signaling pathway. In sickle cell disease, observational studies suggest a potentially protective range of uric acid levels on renal function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Uric acid.